Abstract:Combination therapy via stimulus-responsive drug release is known to improve treatment efficacy and minimize side effects. However, the use of low-abundance cancer biomarkers as molecular triggers to induce efficient drug release for combination therapy still remains a challenge. Herein, we developed a dual microRNA-responsive drug nanocarrier for catalytic release of doxorubicin (Dox) and small interfering RNA (siRNA) in cancerous cells for combined chemotherapy and gene therapy with logic operation. The nanocarrier is constructed by assembling two duplexes of DNA/RNA and Dox molecules onto DNA-functionalized gold nanoparticles. Two microRNA molecules (miRNA-21 and miRNA-10b overexpressed in MDA-MB-231) could alternatively catalyze the disassembly of the nanocarrier through a thermodynamically driven entropy gain process, during which Dox molecules are released, and the two pairs of released DNA/RNA duplex hybridize to generate siRNA (siBcl-2) in situ by strand displacement reactions. Quantum dots are used to track the process in living cells. The AND logic gate-based drug release system allows effective treatment of specific cancer cell types according to miRNA expression patterns. This strategy represents an effective means to overcome multidrug resistance and improve therapeutic effects.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c09494?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c09494</a>.Materials and methods including characterization of GNPs (Figure S1), characterization of DNA2-QD (Figure S2), characterization of DNA hybridization (Figure S3), PAGE analysis of the strand displacement reaction (Figure S4), FL and ICP data for determination of the D1D′1C and D2DQ number (Figure S5), characterization of catalytic disassembly of Dox-GNC (Figure S6), stability test of Dox-GNC (Figure S7), agarose gel electrophoresis characterization of disassembly of GNC (Figure S8), determination of Dox loading on GNC (Figure S9), specificity of Dox-GNC triggered by dual miRNAs for drug release (Figure S10), stability of GNC at physiological circumstances (Figure S11), cell viabilities of three cell lines treated with GRR-Dox in the presence or absence of fuel DNA for different times (Figure S12), cell viabilities of MDA-MB-231 cells transfected with waste DNA (Figure S13), cell viabilities of MDA-MB-231 cells under different treatments (Figure S14), and expression level of the Bcl-2 protein measured with western blot (Figure S15) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c09494/suppl_file/am0c09494_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Endogenous MicroRNA-Triggered and Real-Time Monitored Drug Release Via Cascaded Energy Transfer Payloads

Cell‐Penetrating Poly(disulfide) Assisted Intracellular Delivery of Mesoporous Silica Nanoparticles for Inhibition of Mir‐21 Function and Detection of Subsequent Therapeutic Effects

Photo and Redox Dual Responsive Reversibly Cross-Linked Nanocarrier for Efficient Tumor-Targeted Drug Delivery

Tumor-marker-mediated "On-Demand" Drug Release and Real-Time Monitoring System Based on Multifunctional Mesoporous Silica Nanoparticles.

Dna-Hybrid-Gated Multifunctional Mesoporous Silica Nanocarriers for Dual-Targeted and Microrna-Responsive Controlled Drug Delivery**

Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP As Fuel.

Polytonic Drug Release via Multi-Hierarchical Microstructures Enabled by Nano-Metamaterials

Hierarchical Nanocarriers for Precisely Regulating the Therapeutic Process via Dual-Mode Controlled Drug Release in Target Tumor Cells

In Situ Amplification of Intracellular Microrna with Mnazyme Nanodevices for Multiplexed Imaging, Logic Operation, and Controlled Drug Release

Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release

Dual MicroRNA-Triggered Drug Release System for Combined Chemotherapy and Gene Therapy with Logic Operation

Nanocarriers with Multi-Locked DNA Valves Targeting Intracellular Tumor-Related Mrnas for Controlled Drug Release

Smart Drug-Delivery System of Upconversion Nanoparticles Coated with Mesoporous Silica for Controlled Release

Supramolecular Nano-Tracker for Real-Time Tracking of Drug Release and Efficient Combination Therapy

Intelligent Janus nanoparticles for intracellular real-time monitoring of dual drug release

A Multifunctional Nanocrystalline CaF2:Tm,Yb@mSiO2 System for Dual‐Triggered and Optically Monitored Doxorubicin Delivery

ROS-triggered self-accelerating drug release nanosystem with charge conversion for enhanced cancer therapy

Near-Infrared-Light-Responsive Lipid Nanoparticles As an Intelligent Drug Release System for Cancer Therapy

Highly cell-penetrating and ultra-pH-responsive nanoplatform for controlled drug release and enhanced tumor therapy

Dual-Targeted Nanocarrier Based on Cell Surface Receptor and Intracellular Mrna: an Effective Strategy for Cancer Cell Imaging and Therapy

Nanogram-scale co-delivery of Hesperidin and Bicelin with high performance by Redox- and NIR-responsive nanotheranostic carrier